Real-world evidence bridging clinical trials and routine clinical practice to improve patient care

Real-world evidence (RWE) has emerged as an essential complement to randomized controlled trial data, providing insights into the effectiveness, safety, and tolerability of healthcare interventions in routine practice. The increasing digitalization of healthcare systems has enabled the generation of vast amounts of real-world data (RWD) from electronic medical records, claims databases, and digital health technologies. When appropriately analyzed, these data can inform clinical decision-making, regulatory evaluations, payer assessments, and healthcare resource optimization. Despite its growing importance, the generation of high-quality RWE presents significant methodological and operational challenges. Common challenges such as misclassification bias, confounding, incomplete longitudinal follow-up, poor data linkage, and risks of selective reporting. Addressing these challenges requires rigorous study designs, transparent methodologies, pre-specified and publicly registered protocols, and adherence to standard reporting guidelines. Advances in artificial intelligence (AI) and natural language processing hold promise for improving data accuracy, addressing time-varying confounding, scalability, efficiency, and enhancing study reproducibility. However, AI-driven approaches currently serve as supportive tools rather than autonomous solutions and require robust scientific oversight to ensure appropriate study design, causal reasoning, and clinical contextualization. This article highlights key principles, challenges, and emerging trends in RWE generation and dissemination, with a focus on the role of methodological rigor and expert scientific communication. Agencies and medical communication experts play a crucial role in ensuring that RWE generation aligns with stakeholder needs, regulatory frameworks, and scientific integrity. By leveraging innovative methodologies, robust protocols, transparent reporting, and stakeholder-focused dissemination strategies, RWE can reach its full potential in transforming patient care and driving evidence-based decision-making across healthcare systems.

Authors

Institutions

Publication Details

Journal
Current Medical Research and Opinion
Published
2026-05-12
DOI
https://doi.org/10.1080/03007995.2026.2662089
Primary Topic
Meta-analysis and systematic reviews
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world evidence bridging clinical trials and routine clinical practice to improve patient care

Wendy D’Souza, Emilie Mai Anderberg, Sonali Dalwadi, Vidula Bhole
Current Medical Research and Opinion
Meta-analysis and systematic reviews
article

Real-world evidence bridging clinical trials and routine clinical practice to improve patient care

Wendy D’Souza, Emilie Mai Anderberg, Sonali Dalwadi, Vidula Bhole
article en

Abstract

Real-world evidence (RWE) has emerged as an essential complement to randomized controlled trial data, providing insights into the effectiveness, safety, and tolerability of healthcare interventions in routine practice. The increasing digitalization of healthcare systems has enabled the generation of vast amounts of real-world data (RWD) from electronic medical records, claims databases, and digital health technologies. When appropriately analyzed, these data can inform clinical decision-making, regulatory evaluations, payer assessments, and healthcare resource optimization. Despite its growing importance, the generation of high-quality RWE presents significant methodological and operational challenges. Common challenges such as misclassification bias, confounding, incomplete longitudinal follow-up, poor data linkage, and risks of selective reporting. Addressing these challenges requires rigorous study designs, transparent methodologies, pre-specified and publicly registered protocols, and adherence to standard reporting guidelines. Advances in artificial intelligence (AI) and natural language processing hold promise for improving data accuracy, addressing time-varying confounding, scalability, efficiency, and enhancing study reproducibility. However, AI-driven approaches currently serve as supportive tools rather than autonomous solutions and require robust scientific oversight to ensure appropriate study design, causal reasoning, and clinical contextualization. This article highlights key principles, challenges, and emerging trends in RWE generation and dissemination, with a focus on the role of methodological rigor and expert scientific communication. Agencies and medical communication experts play a crucial role in ensuring that RWE generation aligns with stakeholder needs, regulatory frameworks, and scientific integrity. By leveraging innovative methodologies, robust protocols, transparent reporting, and stakeholder-focused dissemination strategies, RWE can reach its full potential in transforming patient care and driving evidence-based decision-making across healthcare systems.

Current Medical Research and Opinion
Clinical Research Management (US)
Openalex Percentile: Top 5%
Meta-analysis and systematic reviews
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.